Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, USA.
Nat Chem. 2013 Jan;5(1):54-60. doi: 10.1038/nchem.1504. Epub 2012 Nov 25.
The pyridine heterocycle continues to play a vital role in the development of human medicines. More than 100 currently marketed drugs contain this privileged unit, which remains highly sought after synthetically. We report an efficient means to access di- and trisubstituted pyridines in an efficient and highly controlled manner using transient 3,4-pyridyne intermediates. Previous efforts to employ 3,4-pyridynes for the construction of substituted pyridines were hampered by a lack of regiocontrol or the inability to later manipulate an adjacent directing group. The strategy relies on the use of proximal halide or sulfamate substituents to perturb pyridyne distortion, which in turn governs regioselectivities in nucleophilic addition and cycloaddition reactions. After trapping of the pyridynes generated in situ, the neighbouring directing groups may be removed or exploited using versatile metal-catalysed cross-coupling reactions. This methodology now renders 3,4-pyridynes as useful synthetic building blocks for the creation of highly decorated derivatives of the medicinally privileged pyridine heterocycle.
吡啶杂环在人类药物的开发中继续发挥着至关重要的作用。目前有 100 多种上市药物含有这个特权单元,它在合成上仍然备受追捧。我们报告了一种使用瞬态 3,4-吡啶基中间体以高效和高度可控的方式获得二取代和三取代吡啶的有效方法。以前使用 3,4-吡啶基来构建取代吡啶的努力受到缺乏区域控制或无法后续操作相邻导向基团的阻碍。该策略依赖于使用近端卤化物或磺酰胺取代基来干扰吡啶扭曲,这反过来又控制亲核加成和环加成反应的区域选择性。在原位生成的吡啶基被捕获后,相邻的导向基团可以使用多功能金属催化交叉偶联反应来去除或利用。该方法现在使 3,4-吡啶基成为创建高度修饰的药用特权吡啶杂环衍生物的有用合成砌块。